Euronext and Nasdaq-listed global healthcare company, Sanofi, has entered into an agreement to acquire US-listed Vigil Neuroscience, a publicly traded clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative…
France: Sanofi adding to neurology pipeline with acquisition of Vigil Neuroscience
-
Related Articles
More From Author
…
…






